Short interest in Black Diamond Therapeutics Inc (NASDAQ:BDTX) decreased during the last reporting period, falling from 6.40M to 6.36M. This put 18.92% of the company's publicly available shares short.

Short interest for Black Diamond Therapeutic gives investors a sense of the degree to which investors are betting on the decline of Black Diamond Therapeutic's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 472.11K shares traded per day, it would take 13.47 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.